Guangzheng Eye Hospital Group Co.,Ltd. (SHE:002524)

SHE:002524 Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Net Income	2.98	-19.5	-174.65	9.26	-78.22	36.93
Depreciation & Amortization	91.35	91.35	95.76	100.33	100.02	106.39
Other Amortization	10.42	10.42	11.15	14.54	14.24	17.13
Loss (Gain) From Sale of Assets	0.2	0.2	-5.02	-1.7	-1.04	-7.2
Asset Writedown & Restructuring Costs	1.62	1.62	134.67	1.35	138.72	5.78
Loss (Gain) From Sale of Investments	-9.41	-9.41	-14.77	-0.79	20.51	-80.62
Provision & Write-off of Bad Debts	-0.43	-0.43	0.79	2.65	1.77	-5.76
Other Operating Activities	36.73	34.36	39.2	38.75	35.25	38.59
Change in Accounts Receivable	-15.49	-15.49	33.4	-54.02	48.7	-23.57
Change in Inventory	-1.89	-1.89	3.05	27.71	-8.7	16.88
Change in Accounts Payable	40.15	40.15	-68.26	-92.22	-146.72	35.77
Change in Other Net Operating Assets	-4.56	-4.56	7.21	4.23	2.01	6.25
Operating Cash Flow	149.57	124.73	69.07	38.91	124.33	145.37
Operating Cash Flow Growth	84.23%	80.57%	77.54%	-68.71%	-14.48%	-6.20%

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Capital Expenditures	-19.14	-29.04	-25.75	-23.42	-40.71	-52.47
Sale of Property, Plant & Equipment	2.43	1.33	7.13	1.89	1.81	3.54
Cash Acquisitions	-	-	-	-	-	-16.2
Divestitures	20.07	-	-	-	-	100.1
Investment in Securities	1.33	12.61	37.45	2.46	-62.19	-33.92
Other Investing Activities	0.1	0.1	0.43	4.73	0.48	0.19
Investing Cash Flow	4.78	-15	19.25	-14.35	-100.62	1.24

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Long-Term Debt Issued	-	357.9	414.55	447.08	290.94	259.17
Long-Term Debt Repaid	-	-461.43	-489.61	-431.2	-303.07	-526.15
Lease Payments	-72.73	-72.73	-70.19	-85.43	-50.68	-59.15
Net Debt Issued (Repaid)	-176.93	-103.53	-75.07	15.88	-12.13	-266.98
Issuance of Common Stock	2.76	-	0.97	24.81	0.46	77.8
Repurchase of Common Stock	-9.84	-9.84	-0.43	-12.28	-3.06	-22.72
Common Dividends Paid	-12.55	-15.08	-16.26	-	-11.89	-16.52
Other Financing Activities	45.91	-0.39	-1.12	-42.34	14.87	18.57
Financing Cash Flow	-150.65	-128.85	-91.9	-13.93	-11.75	-209.85

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Net Cash Flow	3.7	-19.12	-3.57	10.63	11.96	-63.23

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Free Cash Flow	130.43	95.69	43.32	15.48	83.61	92.91
Free Cash Flow Growth	176.95%	120.89%	179.81%	-81.48%	-10.00%	0.01%
Free Cash Flow Margin	16.03%	10.81%	4.85%	1.44%	10.90%	8.89%
Free Cash Flow Per Share	0.25	0.20	0.08	0.03	0.16	0.18
Levered Free Cash Flow	123.44	68.87	19.82	-8.34	-197.02	59.6
Unlevered Free Cash Flow	142.42	90.09	43.81	15.88	-174.31	83.17
Free Cash Flow After Leases	57.7	22.95	-26.87	-69.94	32.93	33.76

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Cash Interest Paid	-	-	-	14.5	-	-
Cash Income Tax Paid	38.46	25.62	24.29	31.8	23.88	30.74
Change in Working Capital	16.12	16.12	-18.04	-125.48	-106.93	34.13

Data Source: S&P Global Market Intelligence Last updated: Oct 22, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 29, 2026

Data Sources Report a data error